A detailed history of Simmons Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Simmons Bank holds 61,573 shares of ABBV stock, worth $11.1 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
61,573
Previous 64,080 3.91%
Holding current value
$11.1 Million
Previous $11 Million 10.63%
% of portfolio
0.89%
Previous 0.84%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$163.84 - $199.33 $410,746 - $499,720
-2,507 Reduced 3.91%
61,573 $12.2 Million
Q2 2024

Jul 26, 2024

SELL
$154.79 - $180.76 $155,409 - $181,483
-1,004 Reduced 1.54%
64,080 $11 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $91,736 - $104,525
-574 Reduced 0.87%
65,084 $11.9 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $43,344 - $48,815
-315 Reduced 0.48%
65,658 $10.2 Million
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $159,506 - $184,652
1,194 Added 1.84%
65,973 $9.83 Million
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $68,772 - $85,583
-519 Reduced 0.79%
64,779 $8.73 Million
Q1 2023

Apr 28, 2023

SELL
$144.61 - $166.54 $84,307 - $97,092
-583 Reduced 0.88%
65,298 $10.4 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $71,506 - $85,754
-517 Reduced 0.78%
65,881 $10.7 Million
Q3 2022

Oct 27, 2022

SELL
$134.21 - $153.93 $43,752 - $50,181
-326 Reduced 0.49%
66,398 $8.91 Million
Q2 2022

Jul 29, 2022

BUY
$137.62 - $174.96 $311,296 - $395,759
2,262 Added 3.51%
66,724 $10.2 Million
Q1 2022

Apr 21, 2022

BUY
$131.98 - $163.75 $145,441 - $180,452
1,102 Added 1.74%
64,462 $10.5 Million
Q4 2021

Jan 28, 2022

SELL
$107.43 - $135.93 $243,651 - $308,289
-2,268 Reduced 3.46%
63,360 $8.58 Million
Q3 2021

Oct 26, 2021

BUY
$106.4 - $120.78 $235,356 - $267,165
2,212 Added 3.49%
65,628 $7.08 Million
Q2 2021

Aug 05, 2021

SELL
$105.21 - $117.21 $159,919 - $178,159
-1,520 Reduced 2.34%
63,416 $7.14 Million
Q1 2021

May 06, 2021

SELL
$102.3 - $112.62 $269,867 - $297,091
-2,638 Reduced 3.9%
64,936 $7.03 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $135,625 - $183,108
-1,685 Reduced 2.43%
67,574 $7.24 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $350,856 - $411,789
-4,084 Reduced 5.57%
69,259 $6.07 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $69,701 - $93,271
950 Added 1.31%
73,343 $7.2 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $86,688 - $131,429
1,344 Added 1.89%
72,393 $5.52 Million
Q4 2019

Jan 31, 2020

SELL
$72.13 - $90.25 $85,762 - $107,307
-1,189 Reduced 1.65%
71,049 $6.29 Million
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $165,133 - $198,537
2,622 Added 3.77%
72,238 $5.47 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $519,489 - $664,029
7,907 Added 12.81%
69,616 $5.06 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $17,202 - $20,246
-223 Reduced 0.36%
61,709 $4.97 Million
Q4 2018

Jan 24, 2019

BUY
$77.85 - $96.01 $376,326 - $464,112
4,834 Added 8.47%
61,932 $5.71 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $80,285 - $89,252
-903 Reduced 1.56%
57,098 $5.4 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $264,132 - $312,528
-2,942 Reduced 4.83%
58,001 $5.37 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $1.3 Million - $1.73 Million
14,078 Added 30.04%
60,943 $5.77 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $74,155 - $81,317
-828 Reduced 1.74%
46,865 $4.53 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $313,836 - $400,865
4,493 Added 10.4%
47,693 $4.24 Million
Q2 2017

Aug 15, 2017

BUY
N/A
43,200
43,200 $3.13 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Simmons Bank Portfolio

Follow Simmons Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simmons Bank, based on Form 13F filings with the SEC.

News

Stay updated on Simmons Bank with notifications on news.